发明名称 |
CONTROLLED-RELEASE FORMULATION COMPRISING TAMSULOSIN HYDROCHLORIDE |
摘要 |
<p>A solid oral controlled-release formulation of tamsulosin hydrochloride in the form of an enteric coated tablet, wherein tamsulosin hydrochloride is ho-mogenously dispersed within a matrix consisting of a mixture of fatty component and hydrophilic component, together with at least one diluent and optionally other pharmaceutically acceptable excipients, exhibiting ex- hibiting a dissolution profile of tamsulosin hydrochloride, as measured in a Type II paddle apparatus in accordance with the dissolution testing method specified in the European Pharmacopoeia at 37±0.5°C and 100 rpm in a 0.1 N HC1 buffer for 2 hours, followed by pH 7.2 buffer for the rest of test: 10-40% during first 2 hours (in HC1), 35-70% after 3 h (in pH 7.2 buffer system), not less than 70% of the declared content after 5 h (in pH 7.2 buffer system).</p> |
申请公布号 |
WO2006016829(A1) |
申请公布日期 |
2006.02.16 |
申请号 |
WO2005PL00052 |
申请日期 |
2005.08.12 |
申请人 |
INSTYTUT FARMACEUTYCZNY;WIACKOWSKI, LECH;SZELEJEWSKI, WIESLAW;ZAREMBA, ANDRZEJ;PESTA-DYNDA, EDYTA;MARCHLEWSKA-CELA, ZOFIA |
发明人 |
WIACKOWSKI, LECH;SZELEJEWSKI, WIESLAW;ZAREMBA, ANDRZEJ;PESTA-DYNDA, EDYTA;MARCHLEWSKA-CELA, ZOFIA |
分类号 |
(IPC1-7):A61K9/00;A61K9/28;A61K9/20;A61K31/18 |
主分类号 |
(IPC1-7):A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|